JP2021532176A5 - - Google Patents
Info
- Publication number
- JP2021532176A5 JP2021532176A5 JP2021524129A JP2021524129A JP2021532176A5 JP 2021532176 A5 JP2021532176 A5 JP 2021532176A5 JP 2021524129 A JP2021524129 A JP 2021524129A JP 2021524129 A JP2021524129 A JP 2021524129A JP 2021532176 A5 JP2021532176 A5 JP 2021532176A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- administered
- seq
- antibody
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862697939P | 2018-07-13 | 2018-07-13 | |
| US62/697,939 | 2018-07-13 | ||
| PCT/IB2019/000720 WO2020012244A2 (en) | 2018-07-13 | 2019-07-11 | Treating ulcerative colitis with brazikumab |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021532176A JP2021532176A (ja) | 2021-11-25 |
| JP2021532176A5 true JP2021532176A5 (https=) | 2022-08-15 |
| JPWO2020012244A5 JPWO2020012244A5 (https=) | 2022-08-15 |
Family
ID=68072845
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021524129A Pending JP2021532176A (ja) | 2018-07-13 | 2019-07-11 | ブラジクマブによる潰瘍性大腸炎の処置 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20210277105A1 (https=) |
| EP (1) | EP3820897A2 (https=) |
| JP (1) | JP2021532176A (https=) |
| KR (1) | KR20210032441A (https=) |
| CN (1) | CN112689643A (https=) |
| AU (1) | AU2019300491A1 (https=) |
| CA (1) | CA3105598A1 (https=) |
| EA (1) | EA202190197A1 (https=) |
| IL (1) | IL279917A (https=) |
| SG (1) | SG11202100185VA (https=) |
| WO (1) | WO2020012244A2 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JO3244B1 (ar) | 2009-10-26 | 2018-03-08 | Amgen Inc | بروتينات ربط مستضادات il – 23 البشرية |
| CN112807428B (zh) * | 2020-06-12 | 2024-08-27 | 江苏荃信生物医药股份有限公司 | 包含抗人白介素23单克隆抗体的药物组合物 |
| US20240199734A1 (en) * | 2022-11-22 | 2024-06-20 | Janssen Biotech, Inc. | Method of Treating Ulcerative Colitis with Anti-IL23 Specific Antibody |
| WO2025170982A2 (en) | 2024-02-06 | 2025-08-14 | Paragon Therapeutics, Inc. | Il-23 antibody compositions and methods of use |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6171586B1 (en) | 1997-06-13 | 2001-01-09 | Genentech, Inc. | Antibody formulation |
| PE20000183A1 (es) | 1997-07-25 | 2000-03-11 | Schering Corp | Citoquinas de mamiferos y reactivos relacionados |
| AU2006265002B2 (en) | 2005-06-30 | 2012-09-20 | Centocor, Inc. | Anti-IL-23 antibodies, compositions, methods and uses |
| DE602006015830D1 (de) | 2005-08-25 | 2010-09-09 | Lilly Co Eli | Anti-il-23-antikörper |
| EP3190125A1 (en) | 2005-08-31 | 2017-07-12 | Merck Sharp & Dohme Corp. | Engineered anti-il-23 antibodies |
| SI1971366T1 (sl) | 2005-12-29 | 2014-10-30 | Janssen Biotech, Inc. | Humana protitelesa anti-il-23, sestavki, postopki in uporabe |
| JP2009540018A (ja) | 2006-06-13 | 2009-11-19 | ザイモジェネティクス， インコーポレイテッド | Ｉｌ−１７およびｉｌ−２３アンタゴニストならびにその使用方法 |
| EP2426145B1 (en) | 2007-02-23 | 2017-01-18 | Merck Sharp & Dohme Corp. | Engineered anti-il-23p19 antibodies |
| AR065420A1 (es) | 2007-02-23 | 2009-06-03 | Schering Corp | Anticuerpos anti-il-23 p19 de ingenieria |
| AR068723A1 (es) | 2007-10-05 | 2009-12-02 | Glaxo Group Ltd | Proteina que se une a antigenos que se une a il-23 humana y sus usos |
| WO2009082624A2 (en) | 2007-12-10 | 2009-07-02 | Zymogenetics, Inc. | Antagonists of il-17a, il-17f, and il-23 and methods of using the same |
| CA2734919C (en) | 2008-08-27 | 2016-08-16 | Schering Corporation | Lyophilized formulations of engineered anti-il-23p19 antibodies |
| CA2757237A1 (en) | 2009-04-01 | 2010-10-14 | Jane Elizabeth Clarkson | Anti-il-23 immunoglobulins |
| EP2435480A1 (en) | 2009-05-27 | 2012-04-04 | Ablynx N.V. | Biparatopic protein constructs directed against il-23 |
| JO3244B1 (ar) | 2009-10-26 | 2018-03-08 | Amgen Inc | بروتينات ربط مستضادات il – 23 البشرية |
| HRP20171939T1 (hr) | 2010-01-15 | 2018-03-23 | Kirin-Amgen, Inc. | Formulacija protutijela i režimi terapije |
| EP2596022A4 (en) | 2010-07-20 | 2014-11-05 | Cephalon Australia Pty Ltd | SPECIFIC ANTIBODIES ANTI-HETERODIMER IL-23 |
| PE20141162A1 (es) | 2010-11-04 | 2014-09-18 | Boehringer Ingelheim Int | Anticuerpos anti-il-23 |
| KR20150128859A (ko) * | 2013-03-15 | 2015-11-18 | 암젠 인크 | 항-il23 항체를 사용하여 크론병을 치료하는 방법 |
-
2019
- 2019-07-11 CA CA3105598A patent/CA3105598A1/en active Pending
- 2019-07-11 CN CN201980046566.9A patent/CN112689643A/zh active Pending
- 2019-07-11 EA EA202190197A patent/EA202190197A1/ru unknown
- 2019-07-11 EP EP19779090.0A patent/EP3820897A2/en not_active Withdrawn
- 2019-07-11 US US17/259,448 patent/US20210277105A1/en not_active Abandoned
- 2019-07-11 AU AU2019300491A patent/AU2019300491A1/en not_active Abandoned
- 2019-07-11 WO PCT/IB2019/000720 patent/WO2020012244A2/en not_active Ceased
- 2019-07-11 KR KR1020217004216A patent/KR20210032441A/ko not_active Ceased
- 2019-07-11 SG SG11202100185VA patent/SG11202100185VA/en unknown
- 2019-07-11 JP JP2021524129A patent/JP2021532176A/ja active Pending
-
2021
- 2021-01-03 IL IL279917A patent/IL279917A/en unknown